Targets for low-density lipoprotein cholesterol levels in patients with stable coronary heart disease: where are we now after the "treating to new targets" (TNT) trial?
Liberopoulos
Evagelos N
EN
Athyros
Vasilios G
VG
Elisaf
Moses S
MS
Mikhailidis
Dimitri P
DP
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069059:Atorvastatin; D001384:Azetidines / Q000627:therapeutic use; D003327:Coronary Disease / Q000097:blood* / Q000517:prevention & control; D004359:Drug Therapy, Combination; D000069438:Ezetimibe; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D008077:Lipoproteins, LDL / Q000097:blood* / Q000187:drug effects; D011758:Pyrroles / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D016896:Treatment Outcome
D000924:Anticholesteremic Agents; D001384:Azetidines; D006538:Heptanoic Acids; D008077:Lipoproteins, LDL; D011758:Pyrroles; D000069059:Atorvastatin; D000069438:Ezetimibe